CARDIFF ONCOLOGY INC's ticker is CRDF and the CUSIP is 14147L108. A total of 59 filers reported holding CARDIFF ONCOLOGY INC in Q3 2023. The put-call ratio across all filers is 0.28 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $194,524 | -5.4% | 139,945 | 0.0% | 0.00% | – |
| Q2 2023 | $205,719 | -10.9% | 139,945 | 0.0% | 0.00% | – |
| Q1 2023 | $230,909 | -41.1% | 139,945 | -50.0% | 0.00% | – |
| Q4 2022 | $391,846 | +81.4% | 279,890 | +100.0% | 0.00% | – |
| Q3 2022 | $216,000 | -29.9% | 139,945 | 0.0% | 0.00% | – |
| Q2 2022 | $308,000 | -82.4% | 139,945 | -80.1% | 0.00% | – |
| Q1 2022 | $1,747,000 | -58.1% | 704,237 | +1.6% | 0.00% | – |
| Q4 2021 | $4,168,000 | -0.9% | 693,445 | +9.8% | 0.00% | – |
| Q3 2021 | $4,206,000 | +27.9% | 631,556 | +27.7% | 0.00% | – |
| Q2 2021 | $3,288,000 | +3155.4% | 494,491 | +4413.4% | 0.00% | – |
| Q1 2021 | $101,000 | -99.8% | 10,956 | -99.6% | 0.00% | -100.0% |
| Q4 2020 | $45,852,000 | – | 2,548,772 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ELKHORN PARTNERS LIMITED PARTNERSHIP | 45,000 | $63 | 0.04% |
| FinDec Wealth Services, Inc. | 16,000 | $22,240 | 0.02% |
| DENVER WEALTH MANAGEMENT, INC. | 18,235 | $25,347 | 0.02% |
| Atom Investors LP | 18,298 | $25,434 | 0.01% |
| Laurion Capital Management LP | 722,100 | $1,003,719 | 0.01% |
| MAI Capital Management | 224,749 | $312,401 | 0.01% |
| Callan Capital, LLC | 31,147 | $43,294 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 25,975 | $36 | 0.00% |
| Tortoise Investment Management, LLC | 15,000 | $20,850 | 0.00% |
| America First Investment Advisors, LLC | 4,000 | $5,560 | 0.00% |